Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and Cystic Fibrosis

phenylmethylsulfonyl fluoride has been researched along with Cystic Fibrosis in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costello, CM1
McQuaid, K1
O'Connor, CM1
Fitzgerald, MX1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and Cystic Fibrosis

ArticleYear
Effect of the addition of protease inhibitors to sputa from cystic fibrosis patients.
    Biochemical Society transactions, 1994, Volume: 22, Issue:1

    Topics: alpha 1-Antitrypsin; Aminocaproic Acid; Cystic Fibrosis; Edetic Acid; Ethylmaleimide; Humans; Isoflu

1994